Details
Stereochemistry | ACHIRAL |
Molecular Formula | C6H5O7.Fe |
Molecular Weight | 244.945 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe+3].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
InChIKey=NPFOYSMITVOQOS-UHFFFAOYSA-K
InChI=1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
Molecular Formula | C6H5O7 |
Molecular Weight | 189.0997 |
Charge | -3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttps://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://www.ncbi.nlm.nih.gov/pubmed/27684194 | https://www.ncbi.nlm.nih.gov/pubmed/17511797 | https://www.ncbi.nlm.nih.gov/pubmed/1427505https://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlCurator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Sources: https://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttps://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://www.ncbi.nlm.nih.gov/pubmed/27684194 | https://www.ncbi.nlm.nih.gov/pubmed/17511797 | https://www.ncbi.nlm.nih.gov/pubmed/1427505https://books.google.ru/books?id=3hLmyma2-MsC&pg=PA241&lpg=PA241&dq=FERRIC+AMMONIUM+CHLORIDE retrieved from A Consumer's Dictionary of Cosmetic Ingredients, 7th Edition: Complete Information About the Harmful and Desirable Ingredients Found in Cosmetics and Cosmeceuticals By Ruth Winterhttps://www.ncbi.nlm.nih.gov/pubmed/27995746 | http://onlinelibrary.wiley.com/doi/10.1002/047084289X.rn01568/abstract?userIsAuthenticated=false&deniedAccessCustomisedMessage=https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.html
Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Ferric Ammonium EDTA Solution is normally used as a photographic chemical for a bleaching agent in the process of colour washing. It is also used as a complexing, and oxidizing agent & as a fertilizer and catalyst. EDTA acid are colourless, water-soluble solid that are widely used to dissolve scale. The usefulness of these ammonium salts arise because of its role as a chelating agent, i.e. its ability to "sequester" metal ions such as Ca2+ and Fe3+.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006927 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21121365 |
|||
Target ID: CHEMBL2364184 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Additrace N Approved UseA source of electrolytes and trace elements as an integral part of a complete intravenous nutritional regimen, for adults and
children over 40 kg. |
|||
Preventing | Parmirin Approved UsePreventive treatment of iron deficiency |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | SANFEROL Approved UseIt has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency. |
|||
Inactive ingredient | Oxycontin Approved UseOxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Launch Date9.0935997E11 |
|||
Palliative | AURYXIA Approved UseFerric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date1.40978881E12 |
PubMed
Title | Date | PubMed |
---|---|---|
[Effects of ferric fluoride compounds on dental enamel]. | 1954 Nov 15 |
|
The formation of ferritin from apoferritin. Catalytic action of apoferritin. | 1973 Oct |
|
Biological availability of iron supplements for rats, chicks and humans. | 1976 Feb |
|
Carcinogenicity studies on natural and man-made fibres with the intraperitoneal test in rats. | 1989 |
|
Effect of physical exercise and vitamin C on absorption of ferric sodium citrate. | 1996 Dec |
|
New phosphate binding agents: ferric compounds. | 1999 Jun |
|
Metal-mediated cyclization of aryl and benzyl glycidyl ethers: a complete scenario. | 2008 Dec 17 |
|
Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions. | 2011 Jun |
|
Oxidative aromatic C-N bond formation: convenient synthesis of N-amino-3-nitrile-indoles via FeBr3-mediated intramolecular cyclization. | 2011 May 21 |
|
Finnish wallpaper pigments in the 18th-19th century: presence of KFe3(CrO4)2(OH)6 and odd pigment mixtures. | 2013 Apr |
|
FeF(3) catalyzed cascade C-C and C-N bond formation: synthesis of differentially substituted triheterocyclic benzothiazole functionalities under solvent-free condition. | 2014 May |
|
Nazarov cyclization of 1,4-pentadien-3-ols: preparation of cyclopenta[b]indoles and spiro[indene-1,4'-quinoline]s. | 2016 Feb 14 |
|
Mechanisms and origins of the switchable regioselectivity of FeBr3-catalyzed [1,2]-aryl and [1,2]-alkyl shifts of α-aryl aldehydes. | 2016 Feb 28 |
|
Superior electrochemical performance of N-doped nanocrystalline FeF(3)/C with a single-step solid-state process. | 2016 Oct 4 |
|
Ferric Chloride-induced Murine Thrombosis Models. | 2016 Sep 5 |
|
Phosphorus recovery from biogas slurry by ultrasound/H(2)O(2) digestion coupled with HFO/biochar adsorption process. | 2017 Feb |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.psh.ca/MSDS/Iron%20Oxide%20Yellow.pdf
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
LD50 (Oral, Rat) > 5 000 mg/kg
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21121365
U251 cells were exposed to yellow iron oxide (alpha-FeOOH) nanoparticles at the doses of 0, 3.75, 15, 60 and 120 ug/mL. The results showed that the alpha-FeOOH nanoparticles reduced the cell viability and induced necrosis and apoptosis in U251 cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Jul 05 23:12:31 UTC 2023
by
admin
on
Wed Jul 05 23:12:31 UTC 2023
|
Record UNII |
63G354M39Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 184.1298
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
||
|
WHO-ATC |
B03AB06
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
||
|
WHO-ATC |
V03AE08
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
||
|
WHO-VATC |
QB03AB06
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Ferric Citrate
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
63G354M39Z
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
1594675
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | RxNorm | ||
|
61300
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
222-536-6
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
219-045-4
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
ALTERNATIVE | |||
|
SUB13838MIG
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
100000078721
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
4538
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
DTXSID0037657
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
144421
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
2338-05-8
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
63G354M39Z
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
Ferric citrate
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
249-117-0
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
ALTERNATIVE | |||
|
28633-45-6
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
CHEMBL3301597
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
112227
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | |||
|
M5318
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
3522-50-7
Created by
admin on Wed Jul 05 23:12:31 UTC 2023 , Edited by admin on Wed Jul 05 23:12:31 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
||
|
SOLVATE->ANHYDROUS | |||
|
SOLVATE->ANHYDROUS | |||
|
SOLVATE->ANHYDROUS | |||
|
PARENT -> SALT/SOLVATE |
|
||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|